newsfilter
← Latest News
PR Newswire·

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...